Ahmed El Rouby
Alexandria, 12345, Egypt
NCT Number: NCT06419998
The goal of this clinical trial is to compare the surgical and functional outcomes of pure transanal endorectal pull-through (TAERPT) and laparoscopic-assistance endorectal pull-through (LAERPT) in pediatric patients presented with Hirschsprung's Disease between 3 months and 18 years old.
The main questions our study aims to answer are:
* Does post-operative continence differs between the two groups? * Does post-operative constipation differs between the two groups? * Does post-operative soiling differs between the two groups * Does post-operative enterocolitis differs between the two groups? * Do post-operative complications differ between the two groups? If there is a comparison group: Researchers will compare between pure transanal endorectal pull-through (TAERPT) and laparoscopic-assistance endorectal pull-through (LAERPT) to see if there is a difference in post-operative continence, constipation, soiling, enterocolitis or complications.
Participants will be divided into two groups; 40 patients will be treated by TAERPT and included in Group A and 30 patients will be treated by LAERPT and included in Group B.
Looking for future studies?
Notify Me3 month–18 year
All sexes
Interventional
Not applicable
Alexandria, 12345, Egypt
Introduction: One-stage treatment of endorectal pull-through for Hirschsprung's disease could be approached through a complete transanal approach or with the assistance of laparoscopy. Our study aims to compare the surgical and functional outcomes of pure transanal endorectal pull-through (TAERPT) and laparoscopic-assistance endorectal pull-through (LAERPT). Material & methods: This retrospective study included 70 pediatric patients presented with Hirschsprung's Disease to Elshatby University Hospital. 40 patients were treated by TAERPT and included in Group A and 30 patients were treated by LAERPT and included in Group B. The two groups were compared as regards the operative data as well as the post-operative outcomes including the time of passage of stools, time of tolerating oral feeding, the duration of hospital stay, and the development of any early postoperative complications. Also, the number of bowel habits, constipation, enterocolitis, abdominal distension, anastomotic stricture, and continence were assessed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients of Group A will be treated totally by pure transanal endorectal pull-through without the assistance of laparoscopy
Patients of Group B will be treated transanal endorectal pull-through but with the assistance of laparoscopy
Time frame: One post-operative year
The two groups will be compared according to post-operative continence whether continent or incontinent by using Abbreviated Baylor Social Continence Scale. the sore ranges from 0 to 24 with the minimum score revealing an excellent result and the highest score revealing the worst result. (Excellent = 0-5, Good = 7-12, Fair = 13-18, Poor = 19-24)
Time frame: One post-operative year
The two groups will be compared according to post-operative constipation whether present or not
Time frame: One post-operative year
The two groups will be compared according to post-operative soiling whether present or not
Time frame: One post-operative year
The two groups will be compared according to post-operative enterocolitis whether present or not
Time frame: One post-operative year
The two groups will be compared according to post-operative complications whether present or not
Egyptian Biomedical Research Network
Network
One Stage Transanal Versus One Stage Laparoscopic-assisted Transanal Endorectal Pull-through in the Management of Hirschsprung's Disease in Pediatric Age Group; A Retrospective Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06489951
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT05590884
Body Indication, Central Nervous System Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05762835
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Sacramento, California, United States
View Trial DetailsNCT06428435
Amblyopia, Brain Diseases
Birmingham, United Kingdom
View Trial Details